Gene editing enhances immunotherapy success by preventing T-cell exhaustion

Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but has not worked in most.

RMIT-led study highlights the urgent need for more drug testing facilities in Australia

Testing of illicit drugs bought online found 35% were not what they said they were, highlighting the urgent need for more local drug testing facilities

March 5, 2024

Intercept loses Ocaliva FDA full approval bid in rare liver disease – Pharmaceutical Technology

The FDA decision comes in the wake of a negative AdCom opinion in September. Image credit: Shutterstock/ Dilok Klaisataporn. On the heels of an unfavourable

November 13, 2024

FDA says all versions of Novo’s GLP-1 weight loss drugs are now available

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.